• Facebook
WRassman,M.D. BaldingBlog
  • Menu

FDA Finds High Systemic Absorption of Sunscreen Ingredients and potential danger especially to children

Jul 5, 2019/by William Rassman, M.D./0 /Hair Loss Causes

Dr. Rassman’s Comments: The following article appeared in Medscape warning of the potential harmful effects of absorption of toxic chemicals when most sun screens are used. Not the only safe sunscreens are highlighted in RED below. This is critical to protect your children from the toxic chemicals in sunscreens. 

Every patient in a small, randomized clinical trial testing over-the-counter (OTC) sunscreens quickly developed systemic levels of active ingredients  that exceeded the 0.5 ng/mL concentration the US Food and Drug Administration (FDA) guidance says should trigger systemic safety testing, FDA researchers report today in JAMA. While the study authors and the authors of an accompanying editorial are careful not to discourage sunscreen use, they call for prompt safety testing of these compounds.

The FDA research team, led by Murali K. Matta, PhD, took on the question of systemic absorption only after the agency tried and failed to get sunscreen manufacturers to produce such data, according to the editorial by Robert M. Califf, MD, a former FDA commissioner now with Duke University School of Medicine in Durham, North Carolina, and Kanade Shinkai, MD, PhD, from the Department of Dermatology, University of California, San Francisco, and editor in chief of JAMA Dermatology.

Matta and colleagues enrolled 24 healthy volunteers in an open-label, randomized trial of four commercially available sunscreen formulations (two sprays, one lotion, and one cream). The primary outcome was the maximum plasma concentration of the active ingredient avobenzone. Secondary outcomes were maximum plasma concentrations of three additional active ingredients: oxybenzone, octocrylene, and ecamsule.

Sunscreens were applied consistent with current labeling — 2 mg of sunscreen per 1 cm2 to 75% of body surface area 4 times per day for 4 days. The researchers collected 30 blood samples over 7 days from each subject. The study was conducted indoors without exposure to heat, sunlight, or humidity, and wasn’t designed to look at differences in absorption by the type of sunscreen formulation, skin type, or age of the user. Matta and colleagues found that on day 1 after 4 applications, 23 of 24  subjects had systemic concentrations greater than 0.5 ng/mL for all active ingredients in the formulation applied. This is the Threshold of Toxicological Concern (TTC) FDA adopted to approximate the highest plasma level below which the carcinogenic risk of any unknown compound would be less than 1 in 100,000 after a single dose. Systemic levels above 0.5 ng/mL were reached quickly: within 6 hours after the first application of avobenzone, 2 hours after application of oxybenzone, and 6 hours after application of octocrylene.

Moreover, the concentration of the agents continued to increase over time, indicating drug accumulation. With avobenzone, the maximum plasma concentration was 4.3 ng/mL at 67.5 hours with one formulation, whereas the maximum oxybenzone reached was 209.6 ng/mL at 57.0 hours with a different formulation. The authors point out that the clinical effects of plasma concentrations greater than 0.5 ng/mL of these compounds is unknown, “necessitating further research.” Among their concerns are prior reports of oxybenzone in human breast milk, amniotic fluid, urine, and blood, and the possible impact of oxybenzone on endocrine activity. “In this preliminary study involving healthy volunteers, application of 4 commercially available sunscreens under maximal use conditions resulted in plasma concentrations that exceeded the threshold established by the FDA for potentially waiving some nonclinical toxicology studies for sunscreens, Matta and colleagues write. “The systemic absorption of sunscreen ingredients supports the need for further studies to determine the clinical significance of these findings. These results do not indicate that individuals should refrain from the use of sunscreen.”

 

In the editorial, Califf and Shinkai explain that approval of OTC sunscreens for prevention of sunburn continues to follow standards from “before the modern era of drug evaluation” and that this needs to change to facilitate accurate risk/benefit analysis. They write, “Sunscreen users reasonably presume that companies that manufacture and sell sunscreens have conducted basic studies to support the safety and effectiveness of their products and that the medical profession would demand high-quality evidence. However, sunscreens have not been subjected to standard drug safety testing, and clinicians and consumers lack data on systemic drug levels despite decades of widespread use.” Absent such data, Califf and Shinkai advise clinicians continue to recommend sun protection for skin cancer prevention based on “strong biological rationale and modest clinical evidence.” Physicians should at least recommend sunscreen formulations containing “generally regarded as safe and effective” (GRASE) ingredients, which are titanium dioxide and zinc oxide, plus the advice to wear protective clothing, hats, and sunglasses, and seek shade.

They write that the most urgent unanswered questions are whether systemic absorption of sunscreen poses risks to human health; the effects of different formulations, skin characteristics, and exposure to sun and water on systemic absorption; and whether systemic absorption in infants and children, who have a higher ratio of body surface to overall size, is different from adults. To that end, they urge a reform of the FDA process to ensure routine safety testing, generation of risk/benefit data, and improved labeling for over-the-counter medications.  The study authors have disclosed no relevant financial relationships. Califf reported serving on the corporate board for Cytokinetics and as the board chair for the People-Centered Research Foundation and receiving consulting fees from Merck, Biogen, Genentech, Eli Lilly, and Boehringer Ingelheim. Shinkai has disclosed no relevant financial relationships.

https://baldingblog.com/wp-content/uploads/2017/09/logo-small-300x62.png 0 0 William Rassman, M.D. https://baldingblog.com/wp-content/uploads/2017/09/logo-small-300x62.png William Rassman, M.D.2019-07-05 04:43:402019-07-04 06:51:52FDA Finds High Systemic Absorption of Sunscreen Ingredients and potential danger especially to children

You might also like

Doctors Gave Me Cortisone Shots for Treating Traction Alopecia, and Now It's Worse!
Does Finasteride increase your sex drive?
The Importance And Power of Sleep To Your Overall Health
In the News - Pittsburgh Steelers Draft Pick Ryan Shazier Has Alopecia Areata
I'm In My Mid-30s and I Have No Hair Loss
Congenital Adrenal Hyperplasia and Hair Loss
Get a virtual consultation with Dr. William Rassman and Dr. Jae Pak for hair loss options. You can learn more by scheduling an appointment.

Reader Comments0

Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share by Mail
Newer Entries Older Entries

Leave a Comment

Want to join the discussion? Feel free to contribute! Note: We do not tolerate offensive language or personal attacks to other readers. Marketing links or commercial advertisements will be deleted.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

( Will not be published )

+ =

Videos

Podcasts

Ask Dr. Rassman

* Your questions may be published (without your contact information).

Over 21 million women and 35 million men in America suffer from hair loss. For many of these people, the psychological impact on their life is debilitating.

Dr. Rassman is a world leading expert in hair loss with over 25 years of experience and over 50,000 satisfied clients.

About

This site exists to educate about hair loss and hair restoration. Real answers from real physicians… daily.

William R. Rassman, M.D.

Categories

  • ACell (41)
  • African American (145)
  • Age (623)
  • April Fools (3)
  • Density (69)
  • Diseases (545)
  • Drugs (4,035)
  • Drugs (Cause Hair Loss) (535)
  • Favorites (89)
  • Female Hair Loss (1,075)
  • FUE (364)
  • Hair Cloning (178)
  • Hair Loss Causes (7,132)
  • Hair Pieces / Systems (115)
  • Hair Products (1,085)
  • Hair Transplantation (2,059)
  • Hairlines (467)
  • Megasession (15)
  • Other (1,254)
  • Other Surgical Procedures (249)
  • Personal Stories (14)
  • Photos (216)
  • Pigments (128)
  • Podcasts (1)
  • Post-Operative (611)
  • Repair (182)
  • Repost (10)
  • Scalp MicroPigmentation (11)
  • Scarring (346)
  • Thinning (7)
  • Tidbits (34)
  • Training (173)
  • Videos (58)

Archives

  • February 2021 (69)
  • January 2021 (65)
  • December 2020 (80)
  • November 2020 (76)
  • October 2020 (80)
  • September 2020 (106)
  • August 2020 (96)
  • July 2020 (95)
  • June 2020 (84)
  • May 2020 (83)
  • April 2020 (118)
  • March 2020 (106)
  • February 2020 (96)
  • January 2020 (104)
  • December 2019 (103)
  • November 2019 (71)
  • October 2019 (85)
  • September 2019 (76)
  • August 2019 (68)
  • July 2019 (64)
  • June 2019 (62)
  • May 2019 (59)
  • April 2019 (72)
  • March 2019 (53)
  • February 2019 (61)
  • January 2019 (65)
  • December 2018 (59)
  • November 2018 (42)
  • October 2018 (47)
  • September 2018 (64)
  • August 2018 (68)
  • July 2018 (62)
  • June 2018 (72)
  • May 2018 (68)
  • April 2018 (59)
  • March 2018 (65)
  • February 2018 (44)
  • January 2018 (57)
  • December 2017 (48)
  • November 2017 (37)
  • October 2017 (56)
  • September 2017 (68)
  • August 2017 (79)
  • July 2017 (70)
  • June 2017 (82)
  • May 2017 (98)
  • April 2017 (49)
  • March 2017 (25)
  • February 2017 (42)
  • January 2017 (74)
  • December 2016 (10)
  • November 2016 (3)
  • October 2016 (8)
  • June 2016 (2)
  • May 2016 (1)
  • April 2016 (9)
  • March 2016 (6)
  • February 2016 (4)
  • January 2016 (6)
  • December 2015 (7)
  • November 2015 (9)
  • October 2015 (13)
  • September 2015 (15)
  • August 2015 (24)
  • July 2015 (17)
  • June 2015 (19)
  • May 2015 (21)
  • April 2015 (27)
  • March 2015 (42)
  • February 2015 (41)
  • January 2015 (39)
  • December 2014 (45)
  • November 2014 (45)
  • October 2014 (65)
  • September 2014 (60)
  • August 2014 (62)
  • July 2014 (73)
  • June 2014 (49)
  • May 2014 (59)
  • April 2014 (57)
  • March 2014 (59)
  • February 2014 (60)
  • January 2014 (63)
  • December 2013 (53)
  • November 2013 (55)
  • October 2013 (69)
  • September 2013 (61)
  • August 2013 (66)
  • July 2013 (64)
  • June 2013 (60)
  • May 2013 (67)
  • April 2013 (66)
  • March 2013 (63)
  • February 2013 (59)
  • January 2013 (66)
  • December 2012 (59)
  • November 2012 (74)
  • October 2012 (86)
  • September 2012 (72)
  • August 2012 (88)
  • July 2012 (80)
  • June 2012 (80)
  • May 2012 (83)
  • April 2012 (79)
  • March 2012 (78)
  • February 2012 (80)
  • January 2012 (77)
  • December 2011 (75)
  • November 2011 (75)
  • October 2011 (78)
  • September 2011 (78)
  • August 2011 (92)
  • July 2011 (81)
  • June 2011 (88)
  • May 2011 (86)
  • April 2011 (84)
  • March 2011 (91)
  • February 2011 (68)
  • January 2011 (83)
  • December 2010 (82)
  • November 2010 (82)
  • October 2010 (85)
  • September 2010 (86)
  • August 2010 (88)
  • July 2010 (85)
  • June 2010 (89)
  • May 2010 (87)
  • April 2010 (110)
  • March 2010 (114)
  • February 2010 (99)
  • January 2010 (100)
  • December 2009 (97)
  • November 2009 (96)
  • October 2009 (109)
  • September 2009 (106)
  • August 2009 (105)
  • July 2009 (121)
  • June 2009 (132)
  • May 2009 (120)
  • April 2009 (132)
  • March 2009 (132)
  • February 2009 (136)
  • January 2009 (141)
  • December 2008 (142)
  • November 2008 (128)
  • October 2008 (160)
  • September 2008 (146)
  • August 2008 (148)
  • July 2008 (154)
  • June 2008 (146)
  • May 2008 (149)
  • April 2008 (154)
  • March 2008 (147)
  • February 2008 (148)
  • January 2008 (154)
  • December 2007 (127)
  • November 2007 (142)
  • October 2007 (161)
  • September 2007 (135)
  • August 2007 (160)
  • July 2007 (133)
  • June 2007 (141)
  • May 2007 (173)
  • April 2007 (170)
  • March 2007 (178)
  • February 2007 (161)
  • January 2007 (174)
  • December 2006 (132)
  • November 2006 (162)
  • October 2006 (179)
  • September 2006 (166)
  • August 2006 (188)
  • July 2006 (160)
  • June 2006 (179)
  • May 2006 (186)
  • April 2006 (172)
  • March 2006 (201)
  • February 2006 (175)
  • January 2006 (175)
  • December 2005 (179)
  • November 2005 (103)
  • October 2005 (74)
  • September 2005 (68)
  • August 2005 (79)
  • July 2005 (72)
  • June 2005 (69)
  • May 2005 (72)
  • April 2005 (41)

Links

Disclaimer

This site is intended to educate the public on hair loss topics based on personal experience and opinions from Dr. William Rassman and contributing physician editors. Information provided on BaldingBlog.com should not be used for the purpose of medical diagnosis or treatment.

© Copyright - WRassman,M.D. BaldingBlog - Enfold Theme by Kriesi
  • Facebook
Scroll to top